UT-HTL
14.4.2021 12:02:13 CEST | Business Wire | Press release
HTL , the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc. , a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership. The partnership will enable distribution of high-quality HA and glycosaminoglycan (GAG), and the co-development of novel GAG products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005119/en/
The partnership provides academic research and pharmaceutical development laboratories’ expanded access to Good Manufacturing Practices (GMP)-grade, kit-packaged hyaluronic acid and glycosaminoglycan (GAG) products. By offering premium, clinical grade products to early-stage research investigators, the partnership seeks to bridge the gap between lab-based research, development and commercialization, and accelerate innovation worldwide.
“Innovation is at the heart of HTL’s DNA,” said HTL CEO Yvon Bastard . “This growth opportunity reinforces our mission and vision to apply science for increased bio-compatibility and improved health outcomes around the world.”
“This new partnership offers scientists and researchers the key technologies to develop innovative biopolymer solutions for new medical applications in aesthetics, ophthalmology, rheumatology, tissue engineering and drug delivery,” said Charles Ruban , HTL deputy CEO. “This is the true meaning of HTL’s tagline of ‘Beyond, together.’ HTL’s ambition is not only to grow its lead position in producing and distributing hyaluronic acid worldwide, but also to build tomorrow’s glycosaminoglycan-based solutions.”
“Echelon has been granted the opportunity to expand its market-leading HA assays and extra cellular matrix product line with the supply of HTL ’s hyaluronic acid and other GAG-derived products. HTL is recognized internationally for producing biopolymers of premium quality,” says Bert Israelsen , president of Echelon Biosciences . “Echelon offers our customers access to the latest innovative tools with unparalleled technical support, thereby fully enabling maximized creativity in basic and applied research. With its fermentation and organic synthesis platforms, HTL creates functionality and added value by developing chemically modified biopolymers tailored to specific needs.”
“This new partnership is a milestone in HTL’s expanding footprint in the North American market and with the U.S. medical community,” said Glenn Prestwich, Ph.D ., one of Echelon’s founders and now HTL’s exclusive science and innovation advisor for this market. By entrusting Echelon with the distribution of HTL’s hyaluronic acid and glycosaminoglycan products for research use, HTL aims to significantly increase its support and involvement in biopolymer research in the U.S. and worldwide, but also its research and development capacity.
“This new initiative demonstrates HTL’s commitment to invest in innovation in healthcare,” said Humberto C. Antunes , strategic advisor to HTL and former CEO of Galderma. “In the fields of health and wellness, the biotechnology ecosystem of innovation, incubators, and established and emerging companies are incredibly dynamic in the United States, Mexico and Canada. It means a huge growth potential for HTL products,” added Antunes.
About HTL
HTL is a biotechnology company, leading the way in the design and production of pharmaceutical grade hyaluronic acid and other innovative functional biopolymers for premium medical products. HTL serves the pharmaceutical and medical device industries worldwide, enabling them to transform lives of patients. HTL’s unsurpassed commitment to client partnership has been consistently proven in the marketplace. The company is recognized for supplying the highest quality products and continually investing in driving and supporting market growth. For over 25 years, its cutting-edge research and development has allowed to develop unique value-driven solutions to meet the innovation needs of its clients.
About Echelon Biosciences, Inc.
Based in Salt Lake City, Utah, Echelon Biosciences, was established in 1997 to supply synthetic lipid reagents for research and development. Since then, Echelon has successfully grown in scale and scope to include custom chemistry, peptides, and biological assays with over 700 catalog items in the fields of cell signaling, extracellular matrix, cancer drug discovery, and disease biomarkers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005119/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datang Mobile, KPN, NEC and Wilus are Latest Licensors to Join Sisvel POS Patent Pool as Incentive Deadline Nears5.5.2026 10:02:00 CEST | Press release
Datang Mobile, KPN, NEC and Wilus have become the latest licensors in the Sisvel point of sale (POS) patent pool. They join seven other patent owners in making their 2G-5G cellular portfolios available through the programme: BlackBerry, Huawei, JVCKENWOOD, LG Electronics, Nokia, Sisvel and SK Telecom. The period for Sisvel POS licensors to benefit from early participation incentives is set to close on 15 May. Cellular patent owners interested in becoming involved should contact Sisvel as soon as possible. The pool, which is the first in the market to address the POS vertical, was announced at the beginning of April, with Huawei, LG Electronics and Nokia as founding licensors. “We have received a great response from the market so far, and I am pleased to welcome Datang, KPN, NEC and Wilus as the latest licensors,” says POS programme manager Sven Törringer. “We have put together a formidable group of cellular technology innovators, and there are many more companies in the pipeline. I am
Bregal Milestone Announces Majority Growth Investment in meteoviva, an AI-Powered Building Energy Management Solution5.5.2026 10:01:00 CEST | Press release
Partnership to scale one of Europe's largest autonomous energy management solutions amid accelerating decarbonisation mandates and rising AI adoption in commercial real estate Bregal Milestone, a leading European software growth private equity firm, today announced a majority growth investment in meteoviva GmbH (“meteoviva” or the “Company”), a pioneer in AI-powered predictive building energy management. meteoviva's intelligent solutions combine a proprietary physics-based thermodynamic model with AI to deliver energy cost reductions of up to 45 percent across large-scale commercial real estate portfolios, without structural retrofits. meteoviva is widely recognised as a market leader in autonomous building energy management, with over 500 buildings across 19 countries, accounting for 11.5 million square metres of real estate under active control. Its customer base includes some of Europe's most demanding buildings, among them Germany's largest office building, The Squaire at Frankfurt
Schindler Selects Navan to Elevate Global Travel Operations5.5.2026 10:00:00 CEST | Press release
Leading provider of sustainable and smart urban mobility deploys Navan to deliver a seamless experience for its workforce Navan (NASDAQ: NAVN), the global AI-powered business travel and expense management platform, today announced it has been selected by Schindler, the leading provider of sustainable and smart urban mobility, to modernize its global travel program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505725595/en/ Leading provider of sustainable and smart urban mobility deploys Navan to deliver a seamless experience for its workforce With over 150 years of industry innovation, Schindler has reshaped mobility in urban societies, growing from a local manufacturer into a global elevator, escalators and moving walkways business. To support its next phase of growth, the company has chosen to consolidate its travel operations – moving away from a fragmented online booking model. By deploying Navan, Schindler is now u
OCTO and Sedgwick Announce Strategic Telematics Partnership5.5.2026 10:00:00 CEST | Press release
OCTO, a global leader in telematics and data analytics, today announced a strategic partnership with Sedgwick, the world’s leading provider of claims and risk management solutions. Together, the two companies will reshape the future of insurance and mobility by combining advanced telematics with claims management services. The collaboration aims to create a new model where telematics and efficiency come together to transform the customer experience. By integrating OCTO’s cutting-edge telematics insights with Sedgwick’s global expertise in claims handling, the partnership will unlock a series of tangible benefits: enhanced speed and accuracy in crash and claims intake, quicker and more consistent liability assessments, fraud validation and reduction, optimized alerts to improve driver safety, and significant reductions in the overall cost and lifecycle of claims. The joint solution is telematics-agnostic, able to ingest data from connected cars, fleet management systems, or OCTO’s own o
SWISSto12 Partners With German Consortium HPS/LSS on First-Ever Unfurling Antenna Reflector to Be Built in Europe for Commercial GEO Telecommunications Satellite5.5.2026 09:00:00 CEST | Press release
Latest contract awarded signals strong momentum in SWISSto12’s strategy to strengthen European capabilities to build end-to-end space systems SWISSto12 announced today a major contract with German high-performance space subsystem providersHPS/LSS. The Munich-based consortium will provide a large deployable reflector subsystem (LDRS) for the NEASTAR-1 mission, built on HummingSat, enabling the world’s first direct-to-device media broadcasting capabilities from geostationary orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505082353/en/ SWISSto12 enables world-first approach to GEO-based D2D connectivity, leveraging an unfurling antenna, in collaboration with HPS/LSS The German-led antenna reflector subsystem is the result of more than 15 years of development under the European Space Agency’s (ESA) Advanced Research in Telecommunications (ARTES) programme, ESA’s Earth Observation Technology Development activities, and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom